(KONT) Kontigo Care - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0007075247
KONT: Alcohol, Addiction, Gambling, Drugs, Mental, Family, Workplace
Kontigo Care AB (publ) is a Swedish healthcare technology company specializing in digital solutions for addiction treatment and mental health support. Founded in 2013 and headquartered in Uppsala, the company has developed a suite of digital tools aimed at addressing various forms of addiction and mental health challenges. Its product portfolio includes Previct Alcohol for alcohol addiction, Previct Gamble for gambling addiction, Previct Drugs for drug addiction, and Previct Mind for mental health support. Additionally, the company offers Previct Family, a tool designed to support families in therapy, and Previct Work, a workplace-focused addiction care solution. Kontigo Cares digital-first approach aligns with the growing demand for accessible and scalable healthcare solutions in Sweden and beyond.
Ticker Symbol: KONT (ST) Exchange: ST Type: common stock Country Origin: Sweden GICS Sub Industry: Health Care Technology
Based on the provided data, here is a 3-month forecast: - Technical Outlook: The stock is currently trading slightly below its 20-day SMA (2.44) and 50-day SMA (2.49), with a 200-day SMA of 2.47. This suggests potential sideways movement in the near term, with support around the 2.30 level. The ATR of 0.14 indicates low volatility, which may limit significant price swings. - Fundamental Outlook: The companys market cap of 87.42M SEK and P/S ratio of 2.16 reflect moderate valuation relative to its revenue. However, the high P/E ratio of 82.67 signals elevated expectations for future earnings. The lack of a forward P/E suggests uncertainty or limited visibility into upcoming financial performance. Investors may focus on upcoming earnings reports and management guidance to assess whether the company can meet growth expectations. The P/B ratio of 1.67 indicates the market values the company slightly above its book value, while the RoE of 1.48% reflects modest returns on equity.
Additional Sources for KONT Stock
KONT Stock Overview
Market Cap in USD | 9m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception |
KONT Stock Ratings
Growth 5y | -8.38% |
Fundamental | -10.7% |
Dividend | 0.0% |
Rel. Strength Industry | 21.7 |
Analysts | - |
Fair Price Momentum | 2.51 SEK |
Fair Price DCF | - |
KONT Dividends
No Dividends PaidKONT Growth Ratios
Growth Correlation 3m | -54.9% |
Growth Correlation 12m | 60.3% |
Growth Correlation 5y | -65.4% |
CAGR 5y | -0.30% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | -0.06 |
Alpha | 24.35 |
Beta | 0.13 |
Volatility | 60.35% |
Current Volume | 90.8k |
Average Volume 20d | 37.9k |
As of March 16, 2025, the stock is trading at SEK 2.64 with a total of 90,817 shares traded.
Over the past week, the price has changed by +10.92%, over one month by +8.20%, over three months by -4.35% and over the past year by +22.79%.
Neither. Based on ValueRay Fundamental Analyses, Kontigo Care is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.68 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KONT as of March 2025 is 2.51. This means that KONT is currently overvalued and has a potential downside of -4.92%.
Kontigo Care has no consensus analysts rating.
According to ValueRays Forecast Model, KONT Kontigo Care will be worth about 2.7 in March 2026. The stock is currently trading at 2.64. This means that the stock has a potential upside of +3.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.2 | 97% |
Analysts Target Price | - | - |
ValueRay Target Price | 2.7 | 3% |